On February 10, the Shenzhen Medical Insurance Public Account released a brief case report on AstraZeneca's suspected fraud in medical insurance: In July 2021, the Shenzhen Municipal Medical Insurance Bureau verified and found that AstraZeneca staff were suspected of fraud and insurance fraud based on the report, and then under the guidance of the National Medical Insurance Bureau, jointly with the Shenzhen Municipal Public Security Bureau and other relevant units to conduct a special investigation and handling; after careful work, successfully cracked the case, smashed a fraud gang suspected of tampering with the genetic test results of tumor patients to defraud the medical insurance fund, and arrested 17 people involved in the case. All criminal compulsory measures have been taken in accordance with the law; at present, the case is being further investigated and handled.